Patient
P2B-123
completed Phase IIA Multicenter, Randomized, Open-Label Phase 2b Study to Investigate the Preliminary Efficacy and Safety of INNO-206 (Doxorubicin-EMCH) Compared to Doxorubicin in Subjects With Metastatic, Locally Advanced, or Unresectable Soft Tissue Sarcoma · The Crown Princess Mary Cancer Centre Westmead (Sydney, Australia) (Dr. Kowalski)
consented 2013-06-13
Adverse events
3
Serious AEs
0
Open data queries
0
Luna dropout signal
—
not on Luna
Adverse events 3
Grade 2 diarrhoea with onset in cycle 6 (2013-10-22); assessed as not related to study drug (unlikely); resolved 2013-10-24.
Grade 2 pyrexia with onset in cycle 2 (2013-08-03); assessed as not related to study drug (not related); resolved 2013-08-06.
Grade 2 thrombocytopenia with onset in cycle 1 (2013-07-07); assessed as related to study drug (probable); resolved 2013-07-16.
Data queries 0
No data queries
The CDM sweep raises queries on inconsistent fields.
Luna engagement
This participant doesn't use Luna
Invite them from the site to track mood, adherence and check-ins.